Sikko Industries (SIKKO)

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

Strengths

• Sales growth of 42.91% and profit growth of 59.23% show strong momentum
• Low debt-to-equity of 0.14 indicates a conservative balance sheet
• Piotroski F-Score of 7/9 suggests solid fundamental health
• Promoter holding of 54.96% aligns management with shareholders
• PEG of 0.63 implies reasonable valuation if growth sustains

Concerns

• P/E of 32.30 leaves little margin of safety if growth decelerates
• ROCE of 10.72% is moderate, and ROE data is unavailable
• No dividend yield means total return depends entirely on capital gains
• Small-cap agrochemical business in a competitive industry lacks an obvious durable moat

AI Analysis

Looking at Sikko Industries, I first ask: what does this business earn on capital? The return on capital employed is 10.72%—respectable but not exceptional. With debt only 14% of equity, the balance sheet is conservative. But I don't see a wide moat; pesticides and agrochemicals are competitive, and a ₹201 Cr market cap company must fight giants. The price of ₹4.68 is not cheap: a P/E of 32.30 means I pay over 32 years of current earnings. However, the growth is real: sales up 42.91% and profit up 59.23%. A PEG of 0.63 suggests that if growth continues, the valuation is not as demanding. The Piotroski F-Score of 7/9 strengthens my confidence in the fundamentals. Still, book value is only ₹1.98, P/B is 2.36, and there is no dividend—you need uninterrupted growth to justify this. The latest quarter shows sales of ₹17 Cr and net profit of ₹2 Cr, so momentum is encouraging, but one quarter is not a trend. The 52-week range of ₹3.20 to ₹6.83 reminds me this is a volatile small-cap, not a stable compounder. Promoter holding at 54.96% is a positive; their interests are aligned with mine. But I would want to see ROE, which is not available, and ROCE move higher. In Buffett's terms, this is a good little growth story but not a wonderful business at a wonderful price. If growth continues, the stock may prove cheap; if it stumbles, the P/E offers no cushion. I would keep it on a watchlist, not make it a large commitment.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer